Brian was diagnosed with multiple myeloma in 2015, and since then has experienced a variety of treatments. He credits the work of the MMRF for making those treatments available, and now is enthusiastically joining up with the MMRF and Janssen Oncology for the Vermont to Quebec challenge. Brian heard about the R2V program through patient friend and fellow rider Tim Nash. These two are looking forward to cycling together and supporting one another both on the road and back home in their support group.
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism & Retina; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension.
About Janssen Oncology